Lencioni R, Caramella D, Bartolozzi C
Department of Radiology, University of Pisa, Italy.
J Comput Assist Tomogr. 1993 Sep-Oct;17(5):723-9. doi: 10.1097/00004728-199309000-00011.
The aim of the present study was to perform a comparative assessment of the contribution of imaging examinations to the evaluation of the response of hepatocellular carcinoma (HCC) to percutaneous ethanol injection (PEI).
Twenty-five small HCCs (< 5 cm in diameter) were treated by means of PEI. The outcome of treatment, established on the basis of percutaneous biopsy and a 10 to 26 month follow-up, was complete necrosis in 23 of 25 cases and tumor persistence in 2 of 25.
While ultrasound proved to be unable to distinguish posttreatment fibrosis from persisting neoplastic tissue, contrast-enhanced CT correctly identified the two cases of treatment failure, which showed the presence of enhancing areas within the lesion. The remaining 23 cases displayed a hypodense appearance, with no contrast enhancement on CT. Magnetic resonance demonstrated ethanol-induced coagulative necrosis as marked hypointensity on T2-weighted images in 21 of 25 cases. In four cases areas of high signal intensity on T2-weighted images within the nodule were observed after PEI: In two cases they were associated with tumor persistence, and in the other two with the presence of liquefactive necrosis.
Our results demonstrate that different necrotic phenomena following ethanol injection therapy of HCCs may result in variable MR appearance. Although the location of hyperintense areas may suggest a differential diagnosis (central hyperintensity being more likely due to necrosis), CT remains the more reliable technique in the assessment of the response of HCC to PEI.
本研究旨在对影像学检查在评估肝细胞癌(HCC)经皮乙醇注射(PEI)治疗反应中的作用进行比较评估。
对25个小肝细胞癌(直径<5 cm)进行PEI治疗。根据经皮活检及10至26个月的随访确定治疗结果,25例中有23例完全坏死,25例中有2例肿瘤持续存在。
超声无法区分治疗后纤维化与残留肿瘤组织,而增强CT正确识别出2例治疗失败病例,这些病例病变内可见强化区域。其余23例在CT上表现为低密度,无强化。磁共振成像显示,25例中有21例在T2加权图像上乙醇诱导的凝固性坏死表现为明显低信号。PEI后,在4例结节内的T2加权图像上观察到高信号区:其中2例与肿瘤持续存在有关,另外2例与液化性坏死有关。
我们的结果表明,HCC乙醇注射治疗后不同的坏死现象可能导致磁共振成像表现各异。尽管高信号区的位置可能提示鉴别诊断(中央高信号更可能是坏死所致),但在评估HCC对PEI的反应时,CT仍然是更可靠的技术。